UCHL5 and colonic neoplasm: In order to gain insight into the mechanisms through which the USP14/UCHL5 inhibitor b-AP15 kills cells, we compared the effect of this compound on HCT116 colon cancer cells and non-malignant hTERT-RPE1 cells.